Innovation in manufacturing technologies must occur to ensure the availability of gene therapies and cell therapies. The rapid advance of gene and modified cell therapies and growing interest in viral ...

Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. To meet patient needs, reliable and cost-effective ...

In the age of generative AI (genAI), vector databases are becoming increasingly important. They provide a critical capability for storing and retrieving high-dimensional vector representations, ...

First announced early this year, KIOXIA's AiSAQ open-source software technology increases vector scalability by storing all RAG database elements on SSDs. It provides tuning options to prioritize ...

Berlin, Germany--(Newsfile Corp. - January 17, 2024) - Qdrant, the leading high-performance, open-source vector database, today announced the availability of Qdrant Cloud on Microsoft Azure, ...

KIOXIA's AiSAQ open-source software opens the door to scalable AI by offloading data from DRAM to SSD storage, and it's now ...

Regulatory requirements stipulate that the production of any agents intended for use in human clinical trials must be performed under current Good Manufacturing Practices (cGMP). 1 Retroviral vector ...

Despite the aggressive cost claims and dramatic scale improvements, AWS is positioning S3 Vectors as a complementary storage ...